Les anti-diabétiques oraux: mise au point [Oral anti-diabetic agents: update]

Détails

ID Serval
serval:BIB_71907D1F1C5C
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Les anti-diabétiques oraux: mise au point [Oral anti-diabetic agents: update]
Périodique
Revue médicale de la Suisse romande
Auteur⸱e⸱s
Ruiz J.
ISSN
0035-3655
Statut éditorial
Publié
Date de publication
09/2001
Volume
121
Numéro
9
Pages
655-61
Langue
français
Notes
Publication types: English Abstract ; Journal Article - Publication Status: ppublish
Résumé
Type 2 diabetes mellitus is one component of the metabolic syndrome. The treatment of the metabolic syndrome includes the control of hyperglycaemia, which represents one aspect of the management of this complex disease. Indeed, the intensive treatment of hyperglycaemia is clearly associated with the prevention of the micro- and macro-vascular complications. This review describes how to use oral antidiabetic agents: sulfonylurea, glinide, biguanide, alpha-glucosidase inhibitors and glitazone.
Mots-clé
Administration, Oral, Diabetes Mellitus, Humans, Hypoglycemic Agents
Pubmed
Création de la notice
03/03/2008 15:31
Dernière modification de la notice
20/08/2019 14:30
Données d'usage